Insiders BeiGene, Ltd. Hong Kong S.E.

Equities

Delayed Hong Kong S.E. Other stock markets 02:42:10 16/05/2024 BST			5-day change	1st Jan Change
100.7 ^HKD	+1.87%		+4.27%	-10.22%

05-09	Beigene Q1 Loss Shrinks as Revenue Grows; Company's Shares Nearly 7% Up	MT
05-08	Sector Update: Health Care Stocks Lean Lower Pre-Bell Wednesday	MT

BeiGene, Ltd. Announces Executive Changes	03-20	CI
Beigene Insider Sold Shares Worth $8,368,017, According to a Recent SEC Filing	03-14	MT
Beigene, Ltd. Announces Board Changes	01-23	CI
BeiGene, Ltd. Announces Board Changes	01-23	CI
Beigene, Ltd. Announces Change of Chair of Audit Committee	14/09/23	CI
Insider Sell: Beigene	02/08/23	MT
Insider Sell: Beigene	27/06/23	MT
Insider Sell: Beigene	27/06/23	MT
Insider Sell: Beigene	27/06/23	MT
Insider Sell: Beigene	09/06/23	MT
Insider Sell: Beigene	10/05/23	MT
BeiGene, Ltd. Announces Directors Names Who Are Not Standing for Re-Election	27/04/23	CI
BeiGene, Ltd. Announces Re-Designation of Anthony C. Hooper as an Independent Non- Executive Director	18/04/23	CI
BeiGene Announces the Appointment of Julius Pryor III as Global Head of Diversity and Health Equity	30/03/23	CI
Insider Sell: BeiGene	13/03/23	MT
Insider Sell: Beigene	17/01/23	MT
Insider Sell: Beigene	12/01/23	MT
Insider Sell: Beigene	11/01/23	MT
Beigene, Ltd. Announces Change of Co-Chair of Scientific Advisory Committee	21/11/22	CI
Insider Sell: Beigene	17/11/22	MT

No results for this search